These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Inhibition of chemokine (CXC motif) ligand 12/chemokine (CXC motif) receptor 4 axis (CXCL12/CXCR4)-mediated cell migration by targeting mammalian target of rapamycin (mTOR) pathway in human gastric carcinoma cells. Chen G; Chen SM; Wang X; Ding XF; Ding J; Meng LH J Biol Chem; 2012 Apr; 287(15):12132-41. PubMed ID: 22337890 [TBL] [Abstract][Full Text] [Related]
24. Involvement of chemokine receptors in breast cancer metastasis. Müller A; Homey B; Soto H; Ge N; Catron D; Buchanan ME; McClanahan T; Murphy E; Yuan W; Wagner SN; Barrera JL; Mohar A; Verástegui E; Zlotnik A Nature; 2001 Mar; 410(6824):50-6. PubMed ID: 11242036 [TBL] [Abstract][Full Text] [Related]
25. Interaction of ligand-receptor system between stromal-cell-derived factor-1 and CXC chemokine receptor 4 in human prostate cancer: a possible predictor of metastasis. Mochizuki H; Matsubara A; Teishima J; Mutaguchi K; Yasumoto H; Dahiya R; Usui T; Kamiya K Biochem Biophys Res Commun; 2004 Jul; 320(3):656-63. PubMed ID: 15240098 [TBL] [Abstract][Full Text] [Related]
26. Involvement of the nuclear factor-κB signaling pathway in the regulation of CXC chemokine receptor-4 expression in neuroblastoma cells induced by tumor necrosis factor-α. Zhi Y; Lu H; Duan Y; Sun W; Guan G; Dong Q; Yang C Int J Mol Med; 2015 Feb; 35(2):349-57. PubMed ID: 25503960 [TBL] [Abstract][Full Text] [Related]
27. Evaluation of a CXCR4 antagonist in a xenograft mouse model of inflammatory breast cancer. Singh B; Cook KR; Martin C; Huang EH; Mosalpuria K; Krishnamurthy S; Cristofanilli M; Lucci A Clin Exp Metastasis; 2010 Apr; 27(4):233-40. PubMed ID: 20229045 [TBL] [Abstract][Full Text] [Related]
28. Human melanoma metastases express functional CXCR4. Scala S; Giuliano P; Ascierto PA; Ieranò C; Franco R; Napolitano M; Ottaiano A; Lombardi ML; Luongo M; Simeone E; Castiglia D; Mauro F; De Michele I; Calemma R; Botti G; Caracò C; Nicoletti G; Satriano RA; Castello G Clin Cancer Res; 2006 Apr; 12(8):2427-33. PubMed ID: 16638848 [TBL] [Abstract][Full Text] [Related]
29. CXC chemokine receptor CXCR4 expression enhances tumorigenesis and angiogenesis of basal cell carcinoma. Chen GS; Yu HS; Lan CC; Chow KC; Lin TY; Kok LF; Lu MP; Liu CH; Wu MT Br J Dermatol; 2006 May; 154(5):910-8. PubMed ID: 16634895 [TBL] [Abstract][Full Text] [Related]
31. Expression of chemokine CXCL12 and its receptor CXCR4 in human epithelial ovarian cancer: an independent prognostic factor for tumor progression. Jiang YP; Wu XH; Shi B; Wu WX; Yin GR Gynecol Oncol; 2006 Oct; 103(1):226-33. PubMed ID: 16631235 [TBL] [Abstract][Full Text] [Related]
32. X4 HIV-1 induces neuroblastoma cell death by interference with CXCL12/CXCR4 interaction. Hatse S; Bridger G; de Clercq E; Schols D Cell Mol Biol (Noisy-le-grand); 2003; 49 Online Pub():OL443-52. PubMed ID: 14995074 [TBL] [Abstract][Full Text] [Related]
33. Clinical importance and therapeutic implications of the pivotal CXCL12-CXCR4 (chemokine ligand-receptor) interaction in cancer cell migration. Arya M; Ahmed H; Silhi N; Williamson M; Patel HR Tumour Biol; 2007; 28(3):123-31. PubMed ID: 17510563 [TBL] [Abstract][Full Text] [Related]
34. Murine B16 melanomas expressing high levels of the chemokine stromal-derived factor-1/CXCL12 induce tumor-specific T cell chemorepulsion and escape from immune control. Vianello F; Papeta N; Chen T; Kraft P; White N; Hart WK; Kircher MF; Swart E; Rhee S; Palù G; Irimia D; Toner M; Weissleder R; Poznansky MC J Immunol; 2006 Mar; 176(5):2902-14. PubMed ID: 16493048 [TBL] [Abstract][Full Text] [Related]
35. Activating and inhibitory Ly49 receptors modulate NK cell chemotaxis to CXC chemokine ligand (CXCL) 10 and CXCL12. Inngjerdingen M; Rolstad B; Ryan JC J Immunol; 2003 Sep; 171(6):2889-95. PubMed ID: 12960311 [TBL] [Abstract][Full Text] [Related]
36. Epithelial chemokine CXCL14 synergizes with CXCL12 Collins PJ; McCully ML; Martínez-Muñoz L; Santiago C; Wheeldon J; Caucheteux S; Thelen S; Cecchinato V; Laufer JM; Purvanov V; Monneau YR; Lortat-Jacob H; Legler DF; Uguccioni M; Thelen M; Piguet V; Mellado M; Moser B FASEB J; 2017 Jul; 31(7):3084-3097. PubMed ID: 28360196 [TBL] [Abstract][Full Text] [Related]
37. Biological/pathological functions of the CXCL12/CXCR4/CXCR7 axes in the pathogenesis of bladder cancer. Nazari A; Khorramdelazad H; Hassanshahi G Int J Clin Oncol; 2017 Dec; 22(6):991-1000. PubMed ID: 29022185 [TBL] [Abstract][Full Text] [Related]
38. Prognostic and Predictive Role of CXC Chemokine Receptor 4 in Metastatic Colorectal Cancer Patients. Ottaiano A; Scala S; Normanno N; Botti G; Tatangelo F; Di Mauro A; Capozzi M; Facchini S; Tafuto S; Nasti G Appl Immunohistochem Mol Morphol; 2020; 28(10):755-760. PubMed ID: 31985548 [TBL] [Abstract][Full Text] [Related]
39. CXCR4-Targeted Necrosis-Inducing Peptidomimetic for Treating Breast Cancer. Akonnor A; Makise M; Kuniyasu A ACS Omega; 2023 Jul; 8(27):24467-24476. PubMed ID: 37457445 [TBL] [Abstract][Full Text] [Related]
40. CXCL12 induces tyrosine phosphorylation of cortactin, which plays a role in CXC chemokine receptor 4-mediated extracellular signal-regulated kinase activation and chemotaxis. Luo C; Pan H; Mines M; Watson K; Zhang J; Fan GH J Biol Chem; 2006 Oct; 281(40):30081-93. PubMed ID: 16905744 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]